Related Experiment Videos
Management of toenail onychomycosis
Summary
Toenail onychomycosis, a common fungal infection, requires effective treatment. Oral antifungals like itraconazole and terbinafine offer higher cure rates than topical options but necessitate careful monitoring due to potential risks.
Area of Science:
- Dermatology
- Mycology
- Pharmacology
Background:
- Onychomycosis accounts for 40% of nail disorders and is increasing.
- Caused primarily by dermatophytes, fungal nail infections impact quality of life.
- Spontaneous resolution is uncommon for mycotic nail infections.
Purpose of the Study:
- To review current treatment modalities for toenail onychomycosis.
- To compare the efficacy and risks of various antifungal treatments.
- To identify effective first-line therapies for fungal nail infections.
Main Methods:
- Review of existing literature on toenail onychomycosis treatments.
- Analysis of efficacy and safety data for topical and oral antifungal agents.
- Comparison of traditional antifungals (griseofulvin, ketoconazole) with newer agents (itraconazole, terbinafine).
Main Results:
- Oral antifungals are more effective than topical treatments for onychomycosis.
- Itraconazole and terbinafine show high cure rates (50-90%) for dermatophyte infections.
- Topical treatments suffer from poor compliance and nail penetration, limiting effectiveness.
Conclusions:
- Oral antifungal therapy offers a greater likelihood of cure for toenail onychomycosis.
- First-line oral agents like itraconazole and terbinafine are recommended.
- Further research into intermittent oral antifungal therapy is warranted to reduce risks and costs.